This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Michigan State University. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Kathy Steece-Collier: Innovator in Parkinson's Disease Treatment
Introduction
Kathy Steece-Collier is a prominent inventor based in Grand Rapids, MI (US). She has made significant contributions to the field of medical research, particularly in the treatment of movement disorders associated with Parkinson's disease. Her innovative work focuses on addressing levodopa-induced dyskinesias, a common complication faced by patients undergoing treatment for Parkinson's disease.
Latest Patents
Kathy Steece-Collier holds a patent for her invention titled "Nurr1 as a genetic target for treating levodopa-induced dyskinesias in Parkinson's disease." This patent outlines methods for treating movement disorders by reducing the activity of Nurr1, a nuclear receptor related 1 protein. The methods described are particularly applicable to subjects suffering from Parkinson's disease who have developed or are at risk of developing levodopa-induced dyskinesia (LID). The invention provides a therapeutic approach that involves administering a composition that effectively reduces Nurr1 activity, thereby offering hope for improved management of dyskinesias in affected patients.
Career Highlights
Kathy Steece-Collier's career is marked by her dedication to advancing medical science and improving patient outcomes. Her research has garnered attention for its potential to transform the treatment landscape for individuals with Parkinson's disease. With her innovative approach, she has positioned herself as a key figure in the field of movement disorder research.
Collaborations
Kathy has collaborated with notable colleagues, including Nicholas Kanaan and Jack W Lipton. These partnerships have further enriched her research endeavors and contributed to the development of effective treatment strategies for movement disorders.
Conclusion
Kathy Steece-Collier's work exemplifies the impact of innovation in the medical field, particularly in addressing the challenges faced by Parkinson's disease patients. Her patent and research efforts highlight the importance of targeting specific genetic factors to improve treatment outcomes. Through her contributions, she continues to inspire advancements in the understanding and management of movement disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile